Women treated with antimuscarinics for overactive bladder syndrome are more likely to be diagnosed with depression after treatment onset than overactive bladder patients not treated with the ...

PITTSBURGH, Dec. 18, 2025 /PRNewswire/ -- A new retrospective study published in the International Urogynecology Journal (DOI: 10.1007/s00192-025-06209-8) by researchers at Allegheny Health Network's ...

In middle-aged and older adults with overactive bladder, the drug selected for treatment may influence the risk for dementia. Investigators conducted a nested case-control study using data from ...

OAB is commonly treated with a class of medicines called anticholinergics or antimuscarinics. These medicines block chemicals in your body that help the bladder to squeeze. By blocking these chemicals ...

Structured behavioral therapy focused on pelvic floor muscle exercise was noninferior to treatment with solifenacin for alleviating overactive bladder symptoms in patients with Parkinson’s disease (PD ...

This is a preview. Log in through your library . Abstract Background: Despite several new medications being Food and Drug Administration-approved for overactive bladder (OAB) and new prescription drug ...

Boston Scientific acquires Valencia Technologies' eCoin bladder dysfunction device, expanding into the $30M+ overactive ...

Please provide your email address to receive an email when new articles are posted on . Patients with overactive bladder had an odds ratio of 1.4 for osteoarthritis. Overactive bladder was not ...

New Managed Care Findings from Kaiser Permanente Described (Primary Nonadherence to Overactive Bladder Medications in an Integrated Managed Care Health Care System) By a News Reporter-Staff News ...